GWAAIS 2022 Academic Conference Series - March

March 23, 2022

Lecture will be focused on mast cell activation syndrome.  This is a disease with multiple symptoms involving different organ systems which can be difficult to diagnose and challenging to manage and treat.
 

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunology and Greater Washington Allergy, Asthma and Immunology Society (GWAAIS). The American College of Allergy, Asthma & Immunology is accredited by the ACCME to provide continuing medical education for physicians.”

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

Allergists and Allied Health Providers

Learning Objectives

Upon completion of this activity, participants should be able to:
1. Diagnose mast cell activation syndrome.
2. Actively manage and treat mast cell activation syndrome.
3. Identify disorders associated with mast cell.

 

Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines an “ineligible company” as companies whose primary business is producing, marketing, re-selling, or distributing health care goods or services, used by or on patients. Examples of such organizations include:

•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers

The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All relevant financial relationships have been mitigated.

Course summary
Available credit: 
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Attendance
Course opens: 
03/23/2022
Course expires: 
12/31/2024
Event starts: 
03/23/2022 - 7:00pm CDT
Event ends: 
03/23/2022 - 8:30pm CDT
Add to calendar: 
Rating: 
0

All identified conflicts of interest have been mitigated.

The individuals listed below disclose the following financial relationships:

Cem Akin, MD
Advisor: Novartis, Blue Print Medicines Researcher: Blueprint Medicines

The following have no relevant financial relationships to disclose:
Theodore Kim, MD

Available Credit

  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Attendance
Please login or create an account to take this course.